Adenosine

Limited reviewed summaryFull monograph review pending

No original GlobalRPh dilution article is available for this record.

Reviewed product information

Applies to

HealthFirst adenosine injection 6 mg/2 mL (3 mg/mL) single-dose vial, adult peripheral IV bolus for paroxysmal supraventricular tachycardia. Excludes stress-imaging infusions.

The adult guides differ on initial dose. Use the U.S. label for dosing. Only preparation and bolus technique are included here.

Preparation sources checked 2026-11-13.

Ready To Use

The 6 mg/2 mL vial contains a ready-to-use solution for rapid peripheral IV bolus administration.

Sources and exact locations

Claim ID: IVR-70-ADENOSINE-001

Review basis: Separately authored institutional guidance

Source 1
ADENOSINE U.S. prescribing information (opens in a new tab)
Exact location: DOSAGE AND ADMINISTRATION (SPL section fa6eeb2a-224a-0985-e053-6394a90ad013); HOW SUPPLIED (SPL section fa6efef9-6154-b885-e053-6294a90acd1e)
Publisher: DailyMed / HF Acquisition Co LLC, DBA HealthFirst
Source family: U.S. product prescribing information
Retrieved: 2026-11-13T14:43:10.907891+00:00
Source 2
Galway adult IV guide: Adenosine (opens in a new tab)
Exact location: Available preparations, Reconstitution and Infusion fluids
Publisher: Galway University Hospitals Medicines Information
Source family: Galway University Hospitals Medicines Information
Retrieved: 2026-11-13T14:43:11.152324+00:00
Separately edited hospital guidance may draw on product labeling. Only overlapping preparation steps are used.

Line Administration

When using an IV line, inject at the port closest to the patient and immediately follow the bolus with a rapid 0.9% sodium chloride flush.

Sources and exact locations

Claim ID: IVR-70-ADENOSINE-002

Review basis: Separately authored institutional guidance

Source 1
ADENOSINE U.S. prescribing information (opens in a new tab)
Exact location: DOSAGE AND ADMINISTRATION (SPL section fa6eeb2a-224a-0985-e053-6394a90ad013)
Publisher: DailyMed / HF Acquisition Co LLC, DBA HealthFirst
Source family: U.S. product prescribing information
Retrieved: 2026-11-13T14:43:10.907891+00:00
Source 2
Galway adult IV guide: Adenosine (opens in a new tab)
Exact location: Methods of intravenous administration, Intravenous bolus
Publisher: Galway University Hospitals Medicines Information
Source family: Galway University Hospitals Medicines Information
Retrieved: 2026-11-13T14:43:11.152324+00:00
Separately edited hospital guidance may draw on product labeling. Only overlapping preparation steps are used.

Product identifiers and clinical review status

Selected prescribing information available. Full monograph review pending.

Selected product identity

Matched to U.S. product NDC 51662-1631 for the preparation statements shown.

View product identifiers and primary-label provenance

Selected product scope: HealthFirst adenosine injection 6 mg/2 mL (3 mg/mL) single-dose vial, adult peripheral IV bolus for paroxysmal supraventricular tachycardia. Excludes stress-imaging infusions.
Field ID: IVR-70-ADENOSINE-META-PRODUCT_SCOPE
Primary source (opens in a new tab) | Product data elements and the claim-specific formulation described in the cited preparation sections
Complete product reconciliation: pending.
Labeler: HF Acquisition Co LLC, DBA HealthFirst
Field ID: IVR-70-ADENOSINE-META-LABELER
Primary source (opens in a new tab) | SPL author/assignedEntity/representedOrganization/name
Complete product reconciliation: pending.
Application number(s): ANDA078686
Field ID: IVR-70-ADENOSINE-META-APPLICATION_NUMBERS
Primary source (opens in a new tab) | SPL subjectOf/approval/id/@extension
Complete product reconciliation: pending.
NDC(s): 51662-1631-1
Field ID: IVR-70-ADENOSINE-META-NDCS
Primary source (opens in a new tab) | SPL manufacturedProduct/asContent/containerPackagedProduct/code/@code and How Supplied
Complete product reconciliation: pending.
DailyMed Set ID: fa6eb0f8-7c41-2e17-e053-6294a90ac8ca
Field ID: IVR-70-ADENOSINE-META-SETID
Primary source (opens in a new tab) | SPL document/setId/@root
Complete product reconciliation: pending.
SPL version: 1
Field ID: IVR-70-ADENOSINE-META-SPL_VERSION
Primary source (opens in a new tab) | SPL document/versionNumber/@value
Complete product reconciliation: pending.
Label printed revision date: Not established
SPL effective date: 2023-04-28
Field ID: IVR-70-ADENOSINE-META-REVISION_DATE
Primary source (opens in a new tab) | SPL document/effectiveTime/@value
Complete product reconciliation: pending.
Retrieved: 2026-11-13T14:43:10.907891+00:00
Field ID: IVR-70-ADENOSINE-META-RETRIEVED_AT
Primary source (opens in a new tab) | Timestamp recorded when source bytes were retrieved
Complete product reconciliation: pending.
Downloaded XML SHA-256: 50cd37656633aaeafff3a005f329414706ecba39250c10cc21f40ecfaf170c00
Field ID: IVR-70-ADENOSINE-META-XML_SHA256
Primary source (opens in a new tab) | SHA-256 computed over the exact downloaded XML bytes
Complete product reconciliation: pending.

What remains to be completed

Extract and verify presentation-specific IV preparation.
Complete indication- and age-specific dosing, incompatibility, monitoring and stability review.
Assess any proposed compounding BUD for the exact formulation, concentration, container and conditions.

All medications Return to medication heading Application top